CD274 and head and neck cancer: Interestingly, in a more general view of the tumor microenvironment context, PD-L1 expressing tumor-infiltrating immune cells, including macrophages and DCs, in head and neck cancer patients have been shown to result in a more favorable prognosis than when PD-L1 is expressed on tumor cells [149].